FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
LabPro Data Management System
K Number: K201405
·
Decision Aug 30, 2020
Classifications
1
FEI Numbers
23
Registration Numbers
23
Same Product Code
288
Applicant Total
270
Review Days
94
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- LabPro Data Management System
- K Number
- K201405
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.1645
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Beckman Coulter, Inc.
- Date Received
- May 28, 2020
- Decision Date
- August 30, 2020
- Product Code
- LON
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LON | System, Test, Automated, Antimicrobial Susceptibility, Short Incubation | FDA class 2 | Microbiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (LON), ordered by most recent decision date.
VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance
FDA 510(k)
FDA Class 2
·Microbiology
VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)
FDA 510(k)
FDA Class 2
·Microbiology
VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL)
FDA 510(k)
FDA Class 2
·Microbiology
BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL)
FDA 510(k)
FDA Class 2
·Microbiology
BD Phoenix Automated Microbiology System - GN Imipenem-relebactam (0.0625/4 - 16/4 µg/mL)
FDA 510(k)
FDA Class 2
·Microbiology
VITEK COMPACT PRO
FDA 510(k)
FDA Class 2
·Microbiology
Other Clearances by Beckman Coulter, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K252169 | Access BNP II | Mar 24, 2026 | Substantially Equivalent |
| K254059 | Access anti-HBc IgM | Mar 13, 2026 | Substantially Equivalent |
| K253687 | Access anti-HBc Total | Feb 19, 2026 | Substantially Equivalent |
| K251995 | Access anti-HAV IgM | Jan 27, 2026 | Substantially Equivalent |
| K250588 | Access Rubella IgG | Nov 17, 2025 | Substantially Equivalent |
| K252580 | iQ200 Series | Sep 10, 2025 | Substantially Equivalent |
| K243846 | Access anti-HAV | Sep 9, 2025 | Substantially Equivalent |
| K243804 | MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan) | Aug 20, 2025 | Substantially Equivalent |
| K250036 | MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 µg/mL) | Aug 15, 2025 | Substantially Equivalent |
| K243483 | Access hsTnI | Aug 1, 2025 | Substantially Equivalent |